Literature DB >> 329507

Ocular onchocerciasis.

J Anderson, H Fuglsang.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 329507

Source DB:  PubMed          Journal:  Trop Dis Bull        ISSN: 0041-3240


× No keyword cloud information.
  8 in total

1.  Onchocerciasis: a potential risk factor for glaucoma.

Authors:  P R Egbert; D W Jacobson; S Fiadoyor; P Dadzie; K D Ellingson
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

2.  Further studies on the treatment of ocular onchocerciasis with diethylcarbamazine and suramin.

Authors:  J Anderson; H Fuglsang
Journal:  Br J Ophthalmol       Date:  1978-07       Impact factor: 4.638

3.  Evaluation of microfilaricidal effects in the cornea from topically applied drugs in ocular onchocerciasis: Trials with levamisole and mebendazole.

Authors:  B R Jones; J Anderson; H Fuglsang
Journal:  Br J Ophthalmol       Date:  1978-07       Impact factor: 4.638

4.  Ocular manifestations of onchocerciasis in a rain forest area of west Africa.

Authors:  H S Newland; A T White; B M Greene; R P Murphy; H R Taylor
Journal:  Br J Ophthalmol       Date:  1991-03       Impact factor: 4.638

5.  Aggregation of equine platelets by Onchocerca cervicalis collagen.

Authors:  L A McConnell; R W Leid
Journal:  Am J Pathol       Date:  1983-03       Impact factor: 4.307

6.  Modulation of equine platelet function by diethylcarbamazine (DEC).

Authors:  K A Kowalski; L A McConnell; D A Sadoff; R W Leid
Journal:  Am J Pathol       Date:  1983-10       Impact factor: 4.307

7.  Further observations on the relationship between ocular onchocerciasis and the head nodule, and on the possible benefit of nodulectomy.

Authors:  H Fuglsang; J Anderson
Journal:  Br J Ophthalmol       Date:  1978-07       Impact factor: 4.638

8.  Changes in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate.

Authors:  A C Bird; H el-Sheikh; J Anderson; H Fuglsang
Journal:  Br J Ophthalmol       Date:  1980-03       Impact factor: 4.638

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.